{
  "figure_1": "Overview of post-translational modifications in breast cancer. LY: Lymphocyte; M: macrophage; DC: dendritic cells; GLUTs: Glucose Transporters; OP: oxidative phosphorylation; TCA: tricarboxylic acid cycle; Ser: serine; Thr: threonine; Asn: asparagine; Lys: lysine; Arg: arginine; Tyr: tyrosine; Cys: cysteine; Cit: citrulline",
  "figure_2": "Pathophysiological processes regulated by protein acetylation in breast cancer",
  "figure_3": "Protein glycosylation promotes the progression of breast cancer",
  "figure_4": "Protein glycosylation regulates the immune microenvironment and anti-tumor immune response",
  "figure_5": "The potential mechanisms of sumoylation and methylation regulating breast cancer",
  "figure_6": "The proposed model for the effects of RNF31 and RBCK1 in breast cancer",
  "figure_7": "The crosstalk between PTMs",
  "figure_8": "The small molecule inhibitors targeting different PTMs in breast cancer"
}